Welcome to Hair Loss Guide
Fda Approved Hair Loss Product Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
You may also listen to this article by using the following controls.
What You Need To Know About Claritin And Hair Loss
from: Nourman MedClaritin is a type of drug that is usually prescribed by doctors to prevent runny nose, watering of the eyes, sneezing, itching and other symptoms of allergies. This drug is effective in treating hives and other types of inflations. In most cases, Claritin can relieve the patients of his or her symptoms in just a short period of time. However, some experts believe that although this drug is effective when it comes to treating symptoms of allergies, Claritin can cause hair loss in some people. According to some studies, Claritin induced hair loss is not really serious and the thinning of the hair can usually be arrested by stopping the medication.
In most cases, the Claritin induced hair loss is not really that extensive this is not really a cause for much alarm. In fact, if you take a closer look into the advantages and the disadvantages of taking Claritin as a form of medication, you will notice that the advantages of taking this drug is definitely a lot more than the disadvantages.
Taking Claritin
Just because Claritin causes hair loss in some people, this does not mean that we should avoid taking this drug at all. Different types of drugs are bound to have some forms of side effects on the body especially if they are not being used according to their purpose. To make sure that you do not suffer from Claritin induced hair loss, consult your doctor before taking Claritin or any other drugs for that matter. Do not attempt to self-medicate if you do not want to end up with some unwanted side effects. Always remember that when it comes to drugs, you are bound to suffer some forms of side effects. You may not feel the side effects of the drugs that you are taking immediately but in the long run, these things will catch up on you.
When discussing the merits and demerits of taking Claritin, do not just limit your discussion with your doctor on the topic of Claritin and hair loss. There are a lot things that you need to know about Claritin other than the fact that it can cause hair loss. If you are not satisfied with the information that you get from your doctor about this drug, do your own research. There are plenty of materials that you can find about Claritin as a form of treatment. Read these materials and educate yourself further.
Fda Approved Hair Loss Product News
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Genentech, a member of the Roche Group , today announced that the company will present important new data from studies of several of its cancer medicines at the 48th Annual Meeting of the American Society of Clinical Oncology , June 1 to 5, 2012, in Chicago.
Read more...ROGAINE® Brand Names Top Entrepreneur and TV Host Bill Rancic as Its Official "Growth Coach®"
MORRIS PLAINS, N.J., May 17, 2012 /PRNewswire/ -- Bill Rancic*, an American entrepreneur, motivational speaker and star of the hit reality show, Giuliana & Bill, has teamed up with ROGAINE® to serve as ...
Read more...Press Release
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company will present important new data from studies of several of its cancer medicines at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), June 1 to 5, 2012, in Chicago.
Read more...Bristol-Myers Squibb Company - Shareholder/Analyst Call
Bristol-Myers Squibb Company (BMY)May 01, 2012 10:00 am ET Executives James M. Cornelius - Non-Executive ChairmanSandra Leung - Senior Vice President, General Counsel and Corporate SecretaryLamberto Andreotti ...
Read more...Trimel Pharmaceuticals Corporation Announces First Quarter 2012 Financial Results and Provides Product Development ...
TORONTO, ONTARIO-- - Trimel Pharmaceuticals Corporation today reported its financial results for the three month period ended March 31, 2012. The Company also provided investors today with an update on ...
Read more...